Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-08-20 | Dr. Fernandes obtained her MSc in India, and did a Ph.D. and post-doctoral fellowship in bacterial cell membranes and clinical and public health microbiology. |
| 2021-04-26 | Dr. Fernandes has more than 40 years of pharmaceutical discovery, development and management experience having held executive leadership positions at pharmaceutical corporations including Bristol-Myers Squibb Pharmaceutical Research Institute, Abbott Laboratories and The Squibb Institute for Medical Research. |
| 2021-10-29 | Dr. Fernandes’ decades of experience in the biotechnology and pharmaceutical industry with specific expertise in anti-infectives as well as her extensive public company experience both as CEO and director qualifies her for service on our Board. |
| 2022-04-25 | Dr. Fernandes’ decades of experience in the biotechnology and pharmaceutical industry with specific expertise in anti-infectives as well as her extensive public company experience both as CEO and director qualifies her for service on our Board. |
| 2022-10-17 | Prabhavathi Fernandes, Ph.D. (4) 68,357 * |
| 2023-04-26 | She obtained her undergraduate and Master’s degree training in India, worked at the University of Ghent, Belgium in Immunochemistry, and received her Ph.D. in Microbiology from Thomas Jefferson University in Philadelphia. |
| 2023-05-22 | Prabhavathi Fernandes, Ph.D. (4) 4,165 * |
| 2023-07-31 | Prabhavathi Fernandes, Ph.D. (4) 4,165 * |
Data sourced from SEC filings. Last updated: 2026-03-05